BioCentury
ARTICLE | Clinical News

InQu regulatory update

October 1, 2007 7:00 AM UTC

FDA granted 510(k) clearance for InQu for use as a bone graft extender in the spine and as a bone graft substitute in the extremities and pelvis. The product is a biopolymer composite of hyaluronic ac...